CXMT reportedly prioritizes China demand, rejecting Apple's DRAM inquiry

CXMT's rejection of Apple's DRAM inquiry is not a commercial decision—it is the inflection point where the global memory market formally bifurcates. On the technical chain, CXMT's production nodes (17-19nm DDR4/DDR5) still trail Samsung and SK Hynix's 1α nm by a generation, so Apple's premium lines carry limited structural dependence. The real shock is supply-pool contraction: locking CXMT's output to domestic demand removes roughly 15-20% of mid-tier tradable DRAM, inflating server and consumer-electronics procurement costs and forcing the Big Three to shift even more capacity toward HBM3E, structurally amplifying the scarcity premium on commodity DRAM. On compliance, BIS entity-list restrictions have already capped CXMT's access to EUV lithography and advanced packaging. "Domestic priority" is a policy directive, not pure commercial logic—this embeds a tail-risk of non-market supply disruption for every foreign chip designer operating in China. Strategic counterplay: Samsung will likely push DDR5 contract prices up another 10-15% while accelerating HBM long-term agreements. Apple's rational response is extending procurement lock-in to 18-24 months and deepening its in-house unified-memory architecture to reduce sensitivity to discrete DRAM granularity. 12-24 month outlook: the DRAM market will accelerate into two parallel systems—"advanced-node/Western" and "mature-node/China." If HBM demand continues to cannibalize Big Three capacity, structural commodity-DRAM shortages may persist into H2 2026. At that point, CXMT's "domestic-first" posture shifts from passive defense to active pricing power—and that is the scenario Apple should genuinely fear.